MED
Price
$18.38
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
112 days until earnings call
TOUR
Price
$1.12
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
14 days until earnings call
Ad is loading...

MED vs TOUR

Header iconMED vs TOUR Comparison
Open Charts MED vs TOURBanner chart's image
Medifast
Price$18.38
Change-$0.00 (-0.00%)
Volume$6.55K
CapitalizationN/A
Tuniu
Price$1.12
Change-$0.00 (-0.00%)
Volume$83.77K
CapitalizationN/A
View a ticker or compare two or three
MED vs TOUR Comparison Chart
Loading...
MED
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TOUR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MED vs. TOUR commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MED is a Buy and TOUR is a Sell.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (MED: $18.81 vs. TOUR: $1.16)
Brand notoriety: MED and TOUR are both not notable
Both companies represent the Other Consumer Services industry
Current volume relative to the 65-day Moving Average: MED: 119% vs. TOUR: 22%
Market capitalization -- MED: $417.52M vs. TOUR: $91.85M
MED [@Other Consumer Services] is valued at $417.52M. TOUR’s [@Other Consumer Services] market capitalization is $91.85M. The market cap for tickers in the [@Other Consumer Services] industry ranges from $121.92B to $0. The average market capitalization across the [@Other Consumer Services] industry is $9.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MED’s FA Score shows that 1 FA rating(s) are green whileTOUR’s FA Score has 0 green FA rating(s).

  • MED’s FA Score: 1 green, 4 red.
  • TOUR’s FA Score: 0 green, 5 red.
According to our system of comparison, MED is a better buy in the long-term than TOUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MED’s TA Score shows that 4 TA indicator(s) are bullish while TOUR’s TA Score has 3 bullish TA indicator(s).

  • MED’s TA Score: 4 bullish, 4 bearish.
  • TOUR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MED is a better buy in the short-term than TOUR.

Price Growth

MED (@Other Consumer Services) experienced а +5.44% price change this week, while TOUR (@Other Consumer Services) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Other Consumer Services industry was -0.75%. For the same industry, the average monthly price growth was +0.25%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

MED is expected to report earnings on Feb 25, 2025.

TOUR is expected to report earnings on Nov 19, 2024.

Industries' Descriptions

@Other Consumer Services (-0.75% weekly)

Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MED($418M) has a higher market cap than TOUR($91.8M). TOUR YTD gains are higher at: 72.876 vs. MED (-72.017). MED has higher annual earnings (EBITDA): 140M vs. TOUR (-164.66M). TOUR has more cash in the bank: 1.17B vs. MED (150M). MED has less debt than TOUR: MED (22M) vs TOUR (28.8M). MED has higher revenues than TOUR: MED (1.07B) vs TOUR (205M).
MEDTOURMED / TOUR
Capitalization418M91.8M455%
EBITDA140M-164.66M-85%
Gain YTD-72.01772.876-99%
P/E Ratio4.12N/A-
Revenue1.07B205M523%
Total Cash150M1.17B13%
Total Debt22M28.8M76%
FUNDAMENTALS RATINGS
MED vs TOUR: Fundamental Ratings
MED
TOUR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5792
PRICE GROWTH RATING
1..100
6550
P/E GROWTH RATING
1..100
42100
SEASONALITY SCORE
1..100
5049

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MED's Valuation (5) in the Specialty Stores industry is somewhat better than the same rating for TOUR (42) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than TOUR’s over the last 12 months.

MED's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as TOUR (100) in the Other Consumer Services industry. This means that MED’s stock grew similarly to TOUR’s over the last 12 months.

MED's SMR Rating (57) in the Specialty Stores industry is somewhat better than the same rating for TOUR (92) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than TOUR’s over the last 12 months.

TOUR's Price Growth Rating (50) in the Other Consumer Services industry is in the same range as MED (65) in the Specialty Stores industry. This means that TOUR’s stock grew similarly to MED’s over the last 12 months.

MED's P/E Growth Rating (42) in the Specialty Stores industry is somewhat better than the same rating for TOUR (100) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than TOUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEDTOUR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 27 days ago
83%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
MED
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TOUR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TARKX30.520.23
+0.76%
Tarkio
SLVCX20.960.03
+0.14%
Saratoga Large Capitalization Value C
SLGAX16.64N/A
N/A
SEI Large Cap F (SIMT)
MRGHX53.31-0.12
-0.22%
MFS Core Equity R3
HIGJX23.39-0.06
-0.26%
Carillon Eagle Growth & Income I